☰

Fred Krebs - Publications

Affiliations: 
Drexel University College of Medicine, Philadelphia, PA, United States 
Area:
Microbiology Biology, Immunology
Tree Info Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mohamed H, Berman R, Connors J, Haddad EK, Miller V, Nonnemacher MR, Dampier W, Wigdahl B, Krebs FC. Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy. Biomedicines. 11. PMID 36672628 DOI: 10.3390/biomedicines11010122  0.384
2021 Mohamed H, Clemen R, Freund E, Lackmann JW, Wende K, Connors J, Haddad EK, Dampier W, Wigdahl B, Miller V, Bekeschus S, Krebs FC. Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection. Plos One. 16: e0247125. PMID 33647028 DOI: 10.1371/journal.pone.0247125  0.422
2020 Mohamed H, Miller V, Jennings SR, Wigdahl B, Krebs FC. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook. Journal of Immunology Research. 2020: 9470102. PMID 32537473 DOI: 10.1155/2020/9470102  0.355
2017 Banerjee A, Li L, Pirrone V, Krebs FC, Wigdahl B, Nonnemacher MR. cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells. Clinical Medicine Insights. Pathology. 10: 1179555717694535. PMID 28469516 DOI: 10.1177/1179555717694535  0.348
2016 Dampier W, Antell GC, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, James T, Devlin KN, Giovannetti T, Libon DJ, Szep Z, ... ... Krebs FC, et al. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status. Journal of Neurovirology. PMID 27400931 DOI: 10.1007/S13365-016-0462-3  0.367
2016 James T, Nonnemacher MR, Wigdahl B, Krebs FC. Defining the roles for Vpr in HIV-1-associated neuropathogenesis. Journal of Neurovirology. PMID 27056720 DOI: 10.1007/S13365-016-0436-5  0.413
2016 Keogan S, Siegert K, Wigdahl B, Krebs FC. Variability in human semen content and its potential effects in the female reproductive tract Journal of Reproductive Biology and Health. 4: 1. DOI: 10.7243/2054-0841-4-1  0.691
2015 Keogan S, Siegert K, Wigdahl B, Krebs FC. Critical Review: Immunomodulation by Seminal Factors and Implications for Male-to-Female HIV-1 Transmission. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 131-7. PMID 25642971 DOI: 10.1097/Qai.0000000000000561  0.743
2012 Lozenski K, Ownbey R, Wigdahl B, Kish-Catalone T, Krebs FC. Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety. Bmc Pharmacology & Toxicology. 13: 9. PMID 23025553 DOI: 10.1186/2050-6511-13-9  0.741
2012 Kortagere S, Madani N, Mankowski MK, Schön A, Zentner I, Swaminathan G, Princiotto A, Anthony K, Oza A, Sierra LJ, Passic SR, Wang X, Jones DM, Stavale E, Krebs FC, et al. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. Journal of Virology. 86: 8472-81. PMID 22647699 DOI: 10.1128/Jvi.05006-11  0.375
2012 Keogan S, Passic S, Krebs FC. Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat. International Journal of Peptides. 2012: 349427. PMID 22319541 DOI: 10.1155/2012/349427  0.749
2012 Pirrone V, Passic S, Wigdahl B, Krebs FC. Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1. Virology Journal. 9: 33. PMID 22281044 DOI: 10.1186/1743-422X-9-33  0.438
2012 McFadden K, Fletcher P, Rossi F, Kantharaju, Umashankara M, Pirrone V, Rajagopal S, Gopi H, Krebs FC, Martin-Garcia J, Shattock RJ, Chaiken I. Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors. Antimicrobial Agents and Chemotherapy. 56: 1073-80. PMID 22083481 DOI: 10.1128/Aac.05555-11  0.428
2012 Hartmann SU, Krebs F, Wigdahl B, Sokal D, Baniecki ML, Owen D, Gerrard S, Kneen E. A Microbicidal Nipple Shield: An Innovative Method for Prevention of Mother-to-Child Transmission Of HIV Through Breastfeeding Gender Medicine. 9: S95. DOI: 10.1016/J.Genm.2011.09.007  0.397
2012 Lozenski K, Kish-Catalone T, Wigdahl B, Krebs F. In Vitro and In Vivo Measures of Microbicide Safety Differ Considerably in a Multiple Exposure Study Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.005  0.701
2012 Krebs F, Pirrone V, Passic S, Wigdahl B. In Vitro Enhancement of HIV-1 Infection as a Potential Contributor to the Clinical Failures of Select Polyanionic Microbicide Candidates Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.004  0.456
2012 Keogan S, Passic S, Wigdahl B, Krebs F. Cationic Cell Penetrating Peptides as Potential Inhibitors of HIV-1 Infection Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.003  0.749
2011 Lozenski K, Kish-Catalone T, Pirrone V, Rando RF, Labib M, Wigdahl B, Krebs FC. Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model Journal of Biomedicine and Biotechnology. 2011. PMID 22131821 DOI: 10.1155/2011/941061  0.756
2011 Pirrone V, Wigdahl B, Krebs FC. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1. Antiviral Research. 90: 168-82. PMID 21439325 DOI: 10.1016/J.Antiviral.2011.03.176  0.398
2011 Pirrone V, Thakkar N, Jacobson JM, Wigdahl B, Krebs FC. Combinatorial approaches to the prevention and treatment of HIV-1 infection. Antimicrobial Agents and Chemotherapy. 55: 1831-42. PMID 21343462 DOI: 10.1128/Aac.00976-10  0.401
2010 Passic SR, Ferguson ML, Catalone BJ, Kish-Catalone T, Kholodovych V, Zhu W, Welsh W, Rando R, Howett MK, Wigdahl B, Labib M, Krebs FC. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1 Biomedicine and Pharmacotherapy. 64: 723-732. PMID 21106331 DOI: 10.1016/J.Biopha.2010.10.001  0.372
2010 Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL. Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. Virology. 408: 80-8. PMID 20880566 DOI: 10.1016/J.Virol.2010.09.004  0.384
2010 Pirrone V, Passic S, Wigdahl B, Rando RF, Labib M, Krebs FC. A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection. Journal of Biomedicine & Biotechnology. 2010: 548749. PMID 20589074 DOI: 10.1155/2010/548749  0.394
2010 Thakkar N, Pirrone V, Passic S, Keogan S, Zhu W, Kholodovych V, Welsh W, Rando R, Labib M, Wigdahl B, Krebs FC. Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 54: 1965-72. PMID 20231400 DOI: 10.1128/Aac.00934-09  0.748
2009 Thakkar N, Pirrone V, Passic S, Zhu W, Kholodovych V, Welsh W, Rando RF, Labib ME, Wigdahl B, Krebs FC. Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 53: 631-8. PMID 19047650 DOI: 10.1128/Aac.00866-08  0.314
2009 Pirrone V, Passic S, Wigdahl B, Krebs F. Clinical Failures of Select Polyanionic Microbicide Candidates may be Predicted by In Vitro Enhancement of HIV-1 Infection Antiviral Research. 82: A65-A66. DOI: 10.1016/J.Antiviral.2009.02.159  0.433
2009 Passic S, Pirrone V, Wigdahl B, Doncel G, Krebs F. Using the Conrad Testing Algorithm to Evaluate the Cytotoxicity and Anti-HIV-1 Activity of Candidate Microbicide Compounds Antiviral Research. 82: A65. DOI: 10.1016/J.Antiviral.2009.02.158  0.403
2009 Lozenski K, Kish-Catalone T, Wigdahl B, Krebs F. Nonoxynol-9 (N-9), After Repeated Applications, Does not Result in Cumulative Damage to the Murine Cervicovaginal Epithelium Antiviral Research. 82: A64-A65. DOI: 10.1016/J.Antiviral.2009.02.156  0.697
2009 Keogan S, Pirrone V, Passic S, Wigdahl B, Krebs F. Induction of HIV-1 Gene Expression in Human Monocytic Cells by the Failed Microbicide Carrageenan Occurs Through Activation of Toll-like Receptor 4 (TLR4) Antiviral Research. 82: A64. DOI: 10.1016/J.Antiviral.2009.02.154  0.733
2009 Thakkar N, Pirrone V, Passic S, Labib M, Rando R, Wigdahl B, Krebs F. Immediate and Persistent Anti-HIV-1 Activity of the Biguanide-based Compound NB325 Involves Specific Interactions with the Viral Co-receptor CXCR4 Antiviral Research. 82: A26. DOI: 10.1016/J.Antiviral.2009.02.041  0.428
2005 Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 430-7. PMID 16154721 DOI: 10.1016/J.Biopha.2005.07.008  0.398
2005 Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF, Wigdahl B. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 438-45. PMID 16154720 DOI: 10.1016/J.Biopha.2005.07.007  0.424
2005 Kish-Catalone T, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S98. DOI: 10.1186/1742-4690-2-S1-S98  0.363
2005 Qian J, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S96. DOI: 10.1186/1742-4690-2-S1-S96  0.406
2005 Pirrone V, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S95. DOI: 10.1186/1742-4690-2-S1-S95  0.404
2005 Thakkar N, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: P94. DOI: 10.1186/1742-4690-2-S1-P94  0.432
2005 Ferguson ML, Miller S, Labib ME, Rando R, Kholodovych V, Welsh W, Wigdahl B, Krebs FC. Retrovirology. 2: P30. DOI: 10.1186/1742-4690-2-S1-P30  0.348
2004 Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrobial Agents and Chemotherapy. 48: 1837-47. PMID 15105142 DOI: 10.1128/Aac.48.5.1837-1847.2004  0.388
2004 Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund CL. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 48: 1614-23. PMID 15105112 DOI: 10.1128/Aac.48.5.1614-1623.2004  0.404
2003 Quiterio S, Grant C, Hogan TH, Krebs FC, Wigdahl B. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 57: 49-56. PMID 12642037 DOI: 10.1016/S0753-3322(02)00332-3  0.363
2003 Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. Journal of Neurovirology. 9: 55-68. PMID 12587069 DOI: 10.1080/13550280390173292  0.301
2002 Hogan TH, Krebs FC, Wigdahl B. Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. Journal of Neurovirology. 8: 21-6. PMID 12491147 DOI: 10.1080/13550280290167911  0.352
2000 Krebs FC, Ross H, McAllister J, Wigdahl B. HIV-I-associated central nervous system dysfunction Advances in Pharmacology. 49: 315-385. PMID 11013768 DOI: 10.1016/S1054-3589(00)49031-9  0.41
1999 Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate Antiviral Research. 43: 157-173. PMID 10551374 DOI: 10.1016/S0166-3542(99)00044-3  0.401
1994 Tillmann M, Krebs FC, Wessner R, Pomeroy SM, Goodenow MM, Wigdahl B. Neuroglial-specific factors and the regulation of retrovirus transcription Advances in Neuroimmunology. 4: 305-318. PMID 7874399 DOI: 10.1016/S0960-5428(06)80271-8  0.303
Show low-probability matches.